# Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

> **NCT02796755** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 30 (actual)

## Conditions studied

- Inflammation
- Fatigue

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02796755
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-10-24
- **Final completion:** 2019-10-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02796755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02796755, "Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02796755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*